[go: up one dir, main page]

GB1316361A - 5h-dibenzazepines - Google Patents

5h-dibenzazepines

Info

Publication number
GB1316361A
GB1316361A GB2587770A GB2587770A GB1316361A GB 1316361 A GB1316361 A GB 1316361A GB 2587770 A GB2587770 A GB 2587770A GB 2587770 A GB2587770 A GB 2587770A GB 1316361 A GB1316361 A GB 1316361A
Authority
GB
United Kingdom
Prior art keywords
compounds
alkyl
formula
alkyl group
dibenzazepines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2587770A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1316361A publication Critical patent/GB1316361A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

1316361 Aminoalkyl-dibenzazepines ROUSSEL UCLAF 28 May 1970 [28 May 1969] 25877/70 Heading C2C The invention comprises compounds of the formula wherein R 1 is a C 1 -C 4 alkyl group, R 2 is H or a C 1 -C 4 alkyl group, and X and X<SP>1</SP> are each H or halogen; and acid addition salts thereof. Compounds in which R 2 is alkyl may be obtained by dehydrating a compound of the formula Compounds in which R 2 is H may be obtained by reacting compounds in which R 2 is alkyl with a C 1 -C 4 alkylchloroformate or a cyanogen halide, and rendering alkaline the resulting reaction mixture. Examples are given for the preparation of the compounds. The above compounds may be used in pharmaceutical compositions. The compositions may be administered orally, transcutaneously or rectally and have thymoanaleptic action. The salts are derived from mineral and organic acids. The starting materials and intermediates formed in the above processes are described in Specifications 1,316,362, 1,316,363 and 1,316,364.
GB2587770A 1969-05-28 1970-05-28 5h-dibenzazepines Expired GB1316361A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR696917373A FR2043486B1 (en) 1969-05-28 1969-05-28

Publications (1)

Publication Number Publication Date
GB1316361A true GB1316361A (en) 1973-05-09

Family

ID=9034702

Family Applications (4)

Application Number Title Priority Date Filing Date
GB5298272A Expired GB1316364A (en) 1969-05-28 1970-05-28 5h-dibenz-b,f-azepine derivatives and the preparation thereof
GB2587770A Expired GB1316361A (en) 1969-05-28 1970-05-28 5h-dibenzazepines
GB5298172A Expired GB1316363A (en) 1969-05-28 1970-05-28 Alkoxycarbonyl-acridan derivatives and the preparation thereof
GB5298072A Expired GB1316362A (en) 1969-05-28 1970-11-06 Aminoalky-acridan compounds and the preparation thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB5298272A Expired GB1316364A (en) 1969-05-28 1970-05-28 5h-dibenz-b,f-azepine derivatives and the preparation thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB5298172A Expired GB1316363A (en) 1969-05-28 1970-05-28 Alkoxycarbonyl-acridan derivatives and the preparation thereof
GB5298072A Expired GB1316362A (en) 1969-05-28 1970-11-06 Aminoalky-acridan compounds and the preparation thereof

Country Status (8)

Country Link
JP (1) JPS4939274B1 (en)
CH (2) CH527197A (en)
DE (1) DE2026080C3 (en)
DK (1) DK133979B (en)
FR (1) FR2043486B1 (en)
GB (4) GB1316364A (en)
IL (1) IL34546A (en)
NL (1) NL168831C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH533117A (en) * 1970-05-13 1973-01-31 Ciba Geigy Ag Process for the production of azepine derivatives
FR2201884B1 (en) * 1972-10-09 1975-11-28 Roussel Uclaf
DE3279029D1 (en) * 1981-12-11 1988-10-20 Welsh Nat School Med Luminescent labelling materials and procedures
DE3844954C2 (en) * 1988-02-20 1998-07-16 Hoechst Ag Special chemiluminescent acridine derivatives and their use in luminescent immunoassays
US6002007A (en) * 1988-02-20 1999-12-14 Dade Behring Marburg Gmbh Special chemiluminescent acridine derivatives and the use thereof in luminescence immunoassays
EP0522677B1 (en) * 1991-07-10 1996-12-18 TDK Corporation Method of measuring concentration of immunoreactant using electrochemiluminescence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH414643A (en) * 1962-12-04 1966-06-15 Geigy Ag J R Process for the production of new azepine derivatives

Also Published As

Publication number Publication date
GB1316363A (en) 1973-05-09
FR2043486B1 (en) 1973-07-13
DE2026080A1 (en) 1970-12-03
NL168831C (en) 1982-05-17
IL34546A (en) 1974-06-30
NL168831B (en) 1981-12-16
CH553785A (en) 1974-09-13
NL7007625A (en) 1970-12-01
IL34546A0 (en) 1970-07-19
JPS4939274B1 (en) 1974-10-24
GB1316362A (en) 1973-05-09
DK133979B (en) 1976-08-23
DE2026080B2 (en) 1979-03-22
DK133979C (en) 1977-01-31
FR2043486A1 (en) 1971-02-19
CH527197A (en) 1972-08-31
GB1316364A (en) 1973-05-09
DE2026080C3 (en) 1979-11-15

Similar Documents

Publication Publication Date Title
GB1465661A (en) Stilbene derivatives
GB1316361A (en) 5h-dibenzazepines
GB1322512A (en) Substituted azetidinones and process for their manufacture
GB1459506A (en) Piperidine derivatives
ES266444A1 (en) Derivatives of cephalosporin c
SU517587A1 (en) Method for preparing 2-oxphenylurea derivatives
GB1376713A (en) Process for the preparation of benzimidazol-2-yl-carbamic acid alkyl esters
GB1369795A (en) Process for preparing methacrylate esters of phenol derivatives
GB1075494A (en) Anthranilic acid compounds and methods for their production
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
GB1128079A (en) Process for the manufacture of new cyclohexane derivatives
GB1452411A (en) N,n-disubstituted benzamidines and toluamidines methods for their preparation and compositions containing them
GB1177259A (en) Process for the Preparation of N-hydroxyimidothiocarboxylic Acid Esters
GB1418854A (en) Cyclic sulphoximides
GB1384486A (en) N-alkyl-n-o-tolylanthranilonitriles and their use in the preparation of 5-alkyl-10-amino-dihydrodibenzoazepines
GB1348460A (en) Preparation of 5/6-acyl-benzimidazolyl alkyl carbamates
GB1468874A (en)
GB1529463A (en) Pharmaceutical compositions
GB1419910A (en) Synthesis of itaconic acid from 2,4,4-substituted-2-oxazolines and intermediates thereof
GB1434645A (en) Tetrazole coumarin derivatives
GB1496953A (en) Process for the production of sulphonic acid hydroxy amides
GB1410852A (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
GB1346792A (en) Process and intermediates for preparing benzamide compounds
GB1248359A (en) Preparation of subtituted 1,3-oxathiolium salts
GB1143430A (en) New cyclobutene derivative

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee